Invert Graphite Limited has released a press release.
Appendix 4C - March 2018 Quarter
Filed with ASX ·
6ix hasn’t read this filing yet.
Invert Graphite Limited on 6ix
Earlier from Invert Graphite
- Clinical Trial update - March quarter
- Rights Issue Entitlement Offer Information Booklet
- Appendix 4E Preliminary Final Report
- Appendix 4C - December 2017 Quarter
- Shareholder Update
Later from Invert Graphite
- Clinical trial update - recruitment enters final phase
- Receipt of $1.23M R&D tax incentive
- Clinical Trial Update
- Screening to close as clinical trial nears completion
- Recruitment complete in VF00102 Phase 2 clinical trial
Follow Invert Graphite into a list and get an email when it puts out news.
Follow Invert Graphite